18 Jul 2006

CIMZIA(TM) Shows Promise in Treatment of Psoriasis

Read More
3 Jul 2006

A Key Regulatory Milestone for Keppra®

Read More
13 Jun 2006

UCB Award for Neuroscientific Research Presented to leading Belgian Neuroscience Group

Read More
13 Jun 2006

Statement of the Chief Executive Officer to the Shareholders

Read More
25 May 2006

UCB SELLS TO ADAMS RESPIRATORY THERAPEUTICS OTC DELSYM® 12-HOUR COUGH SUPPRESSANT LIQUIDS

Read More
24 May 2006

UCB Completes Mutual Recognition Procedure for Equasym(TM) XL

Read More
22 May 2006

New CIMZIA (TM) Data from PRECiSE Program Reinforce Robust Efficacy in Once-Monthly Treatment of Crohn's Disease and Consistent Tolerability Profile

Read More
15 May 2006

European Commission Approves Keppra® for Use as Adjunctive Therapy in the Treatment of Myoclonic Seizures in Patients with Juvenile Myoclonic Epilepsy

Read More
10 May 2006

UCB and Immunomedics announce worldwide development collaboration and license agreement for Epratuzumab

Read More
28 Apr 2006

UCB Submits Marketing Authorisation Application in Europe for CIMZIATM, a New Crohn's Disease Therapy

Read More
Subscribe to